ArticleWorld journal of nuclear medicine2023
Theranostics in Developing Countries: Addressing Challenges and Potentials from Training to Practice.
Article in World journal of nuclear medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Organ and tumor dosimetry of [European journal of nuclear medicine and molecular imaging · 2026Article
- Outcome and Safety of Radioligand Therapy With [ 161 Tb]Tb-PSMA-617 After Re-Progression in mCRPC Patients Previously Treated With [ 177 Lu]Lu-PSMA-617.Clinical nuclear medicine · 2026Observational
- Theranostics and nuclear medicine practice in Asia-Pacific: an IAEA regional study.European journal of nuclear medicine and molecular imaging · 2026Review
- Comparison of mCRPC [European journal of nuclear medicine and molecular imaging · 2026Article
- Nuclear Medicine in IRAQ: From a Pioneering Past to Future Progress.Journal of multidisciplinary healthcare · 2026Review
- Theranostics in the management of colorectal cancer.Discover nano · 2025Review
- The Role of Nuclear Medicine in Prostate Cancer.Diagnostics (Basel, Switzerland) · 2025Review
- Theranostics in the Indian Subcontinent: Opportunities, Challenges, and the Path Forward.Nuclear medicine and molecular imaging · 2025Review
- Real Challenges Before, During, and after Establishing a Theranostics Center in Developing Countries.Nuclear medicine and molecular imaging · 2025Review
- Current Status of Theranostics in West Asia: A Country-based Surveillance Study.Nuclear medicine and molecular imaging · 2025Review
- Considerations for Establishing Peptide Receptor Radionuclide Therapy: A Nationally Coordinated, Collaborative, and Equitable Service for New Zealand.World journal of nuclear medicine · 2025Article
- Harnessing Terbium Radioisotopes for Clinical Advancements: A Systematic Review.Nuclear medicine and molecular imaging · 2025Review
- Pilot experience of [Theranostics · 2025Observational
- Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects duringTheranostics · 2025Review
- Efficacy and safety of rechallenge [European journal of nuclear medicine and molecular imaging · 2024Observational
- Analysis of Molecular Imaging Biomarkers Derived from [Cancers · 2024Article
- A New Era for PET/CT: Applications in Non-Tumorous Renal Pathologies.Journal of clinical medicine · 2024Review
- Article
- Guiding principles on the education and practice of theranostics.European journal of nuclear medicine and molecular imaging · 2024Article
- From Despair to Hope: First Arabic Experience ofCancers · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.